NCT01612351 Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery Status COMPLETED Phase PHASE2
NCT01610492 A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy Status COMPLETED Phase PHASE2
NCT01610427 Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects Status COMPLETED Phase NA
NCT01610414 Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A Status COMPLETED Phase PHASE3
NCT01610388 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01608009 [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01607411 A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model Status COMPLETED Phase PHASE3
NCT01607398 ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE4
NCT01607385 A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235. Status COMPLETED Phase PHASE1
NCT01607372 A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies Status COMPLETED Phase PHASE2
NCT01607346 An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures Status TERMINATED Phase PHASE4
NCT01607333 WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide Status COMPLETED Phase N/A
NCT01607112 A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01607086 Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo Status COMPLETED Phase PHASE1
NCT01606761 A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) Status COMPLETED Phase PHASE3
NCT01604343 A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) Status COMPLETED Phase PHASE3
NCT01602913 Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine Status COMPLETED Phase N/A
NCT01602900 Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease Status COMPLETED Phase PHASE1
NCT01602601 A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723 Status COMPLETED Phase N/A